| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $46,079,000 ) (Continued on the next page) |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01DK133702 | Hydrogels for human beta cell survival, function and evasion of immune rejection | 001 | 3 | NIH | 5/13/2024 | $785,689 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI171892 | DNA-gated cytometry for multiplexed sorting of antigen-specific CD8 T cells | 000 | 3 | NIH | 5/13/2024 | $395,500 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AG073250 | Influences of Environmental Geometry and Aging on Cognitive Mapping Mechanisms | 000 | 3 | NIH | 5/9/2024 | $469,040 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 90AREM0006 | ARRT - Equitable Employment across Evolving Work Paradigms | 00 | 2 | ACL | 5/3/2024 | $199,996 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R00EY029326 | Controlling synaptic and intrinsic plasticity underlying visual cortical enhancement | 000 | 5 | NIH | 5/20/2024 | $249,000 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | NU2RGH001919 | Informing global polio eradication efforts through innovative modeling approaches | 00 | 3 | CDC | 7/2/2024 | $100,000 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01DC020048 | Discovering novel predictors of minimally verbal outcomes in autism through computational modeling | 000 | 3 | NIH | 5/8/2024 | $525,830 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F31CA271803 | Focused ultrasound control of intratumoral NKG2DL BTE production by CART cells to potentiate epitope spread | 000 | 3 | NIH | 7/1/2024 | $48,974 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 90DPCP0006 | Accommodation Expert Support System for Aging Well (ACCESS for Aging Well) | 00 | 5 | ACL | 7/1/2024 | $499,941 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA266013 | Development of Novel Targeted Therapeutic Agents for Castration Resistant Prostate Cancer | 000 | 3 | NIH | 5/30/2024 | $535,890 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F31DK130581 | F31 Mulero Russe | 000 | 3 | NIH | 7/2/2024 | $48,974 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 90ARPO0002 | ARRT: Inclusive Technology and Policy Design Research Fellowships | 00 | 5 | ACL | 5/3/2024 | $199,670 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AR077357 | Biomaterials to enhance the efficacy of MSCs for rotator cuff repair | 000 | 4 | NIH | 7/10/2024 | $373,675 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM142588 | Biophysical mechanism and synthetic engineering of optically-controlled Ca2+-powered supramolecular engines | 000 | 4 | NIH | 7/9/2024 | $395,500 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI153116 | Understanding in vivo antibiotic resistance in diverse Pseudomonas aeruginosa populations | 001 | 4 | NIH | 5/23/2024 | $48,063 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI153116 | Understanding in vivo antibiotic resistance in diverse Pseudomonas aeruginosa populations | 000 | 4 | NIH | 3/12/2024 | $432,575 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL158159 | Artery biomechanics and vascular damage in sickle cell disease | 001 | 4 | NIH | 6/12/2024 | $44,789 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL158159 | Artery biomechanics and vascular damage in sickle cell disease | 000 | 4 | NIH | 5/7/2024 | $503,897 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21HD110918 | Functional screen for genetic causes of hypoplastic left heart syndrome | 001 | 2 | NIH | 5/23/2024 | $17,534 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21HD110918 | Functional screen for genetic causes of hypoplastic left heart syndrome | 000 | 2 | NIH | 3/26/2024 | $157,815 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R00EY034546 | Anatomical, Neural, and Computational Constraints On Sensory Cross-Modal Plasticity Following Early Blindness | 000 | 3 | NIH | 7/22/2024 | $248,406 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 90RTEM0010 | RRTC on Accommodations, Employment Supports and Success for People with Physical Disabilities (ACCESS-PD) | 00 | 2 | ACL | 7/22/2024 | $874,996 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R33CA291197 | Spatial protein-protein interaction networks in situ by multiplexed proximity ligation | 000 | 1 | NIH | 7/18/2024 | $374,123 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | AY2AX000006 | Mapping the Cancer and Organ Degradome Atlas (CODA) to Unlock Synthetic Biomarkers for Multi-Cancer Early Detection | 002 | 1 | NIH | 3/29/2024 | $10,875,289 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 2401GAATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 3 | 1 | ACL | 5/20/2024 | $376,983 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 2401GAATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 2 | 1 | ACL | 3/15/2024 | $96,524 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 2401GAATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 0 | 1 | ACL | 10/30/2023 | $94,505 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 2401GAATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 1 | 1 | ACL | 12/12/2023 | $151,670 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA268125 | Mechanisms underlying spontaneous firing by motoneurons with acute neurotoxicity | 001 | 3 | NIH | 4/17/2024 | $24,365 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | R01CA268125 | Mechanisms underlying spontaneous firing by motoneurons with acute neurotoxicity | 000 | 3 | NIH | 1/15/2024 | $438,569 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | R01MH130064 | Modularly built, complete, coordinate- and template-free brain atlases | 000 | 3 | NIH | 1/22/2024 | $578,655 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM139594 | Identification and study of adaptive mutations and phenotypes using laboratory growth of C. elegans | 001 | 4 | NIH | 7/9/2024 | -$355,950 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM139594 | Identification and study of adaptive mutations and phenotypes using laboratory growth of C. elegans | 001 | 4 | NIH | 7/9/2024 | $395,500 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | R35GM139594 | Identification and study of adaptive mutations and phenotypes using laboratory growth of C. elegans | 000 | 4 | NIH | 12/19/2023 | $355,950 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI181282 | Hydrogel-Based Aged Immune Organoids to Study Epigenetics and Trajectory of B Cells | 001 | 1 | NIH | 7/17/2024 | -$520,844 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI181282 | Hydrogel-Based Aged Immune Organoids to Study Epigenetics and Trajectory of B Cells | 001 | 1 | NIH | 7/17/2024 | $520,844 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI181282 | Hydrogel-Based Aged Immune Organoids to Study Epigenetics and Trajectory of B Cells | 000 | 1 | NIH | 7/12/2024 | $695,893 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F32EY036268 | The Structural and Biochemical Effects of XFG-Associated Variants in LOXL1 | 002 | 1 | NIH | 5/3/2024 | $0 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F32EY036268 | The Structural and Biochemical Effects of XFG-Associated Variants in LOXL1 | 001 | 1 | NIH | 5/3/2024 | $4,784 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F32EY036268 | The Structural and Biochemical Effects of XFG-Associated Variants in LOXL1 | 000 | 1 | NIH | 3/18/2024 | $69,500 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM152245 | Integrative predictive medicine to identify disease causes, develop cures, and optimize patient care | 000 | 1 | NIH | 4/15/2024 | $366,688 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM136404 | Molecular Tools to Illuminate Copper Transport and Homeostasis | 001 | 5 | NIH | 5/16/2024 | $38,511 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM136404 | Molecular Tools to Illuminate Copper Transport and Homeostasis | 000 | 5 | NIH | 3/15/2024 | $346,604 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | T32EB021962 | T32 Research Training Program in ImmunoEngineering | 004 | 7 | NIH | 7/19/2024 | $0 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | T32EB021962 | T32 Research Training Program in ImmunoEngineering | 003 | 7 | NIH | 7/12/2024 | $212,534 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL175067 | Mechanosensing in lung fibrosis | 000 | 1 | NIH | 7/12/2024 | $545,400 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F31HL174122 | Investigating the Effectiveness and Mechanisms of Lymphaticovenous Anastomoses (LVA) for Lymphedema Treatment: Integrating Computational Modeling with Clinical LVA Insights | 001 | 1 | NIH | 3/18/2024 | $0 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL173943 | Lymphedema therapy via lymphatic targeted drug delivery | 000 | 1 | NIH | 4/1/2024 | $664,892 |
| 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F31HL174122 | Investigating the Effectiveness and Mechanisms of Lymphaticovenous Anastomoses (LVA) for Lymphedema Treatment: Integrating Computational Modeling with Clinical LVA Insights | 000 | 1 | NIH | 3/18/2024 | $47,694 |
|